Inhibition of receptor activator of nuclear factor kappa‐B ligand‐mediated osteoclast differentiation and bone resorption by Gryllus bimaculatus extract: An in vitro study

Abstract

AbstractExcessive bone‐resorbing osteoclast activity during bone remodeling is a major feature of bone diseases, such as osteoporosis. Therefore, the inhibition of osteoclast formation and bone resorption can be an effective therapeutic target for various bone diseases. Gryllus biomaculatus (GB) has recently been approved as an alternative food source because of its high nutritional value and environmental sustainability. Traditionally, GB has been known to have various pharmacological properties, including antipyretic and blood pressure‐lowering activity, and it has recently been reported to have various biological activities, including protective effects against inflammation, oxidative stress, insulin resistance, and alcohol‐induced liver injury. However, the effect of GB on osteoclast differentiation and bone metabolism has not yet been demonstrated. In this study, we confirmed the inhibitory effect of GB extract (GBE) on the receptor activator of nuclear factor‐κB ligand (RANKL)‐induced osteoclast formation. To determine the effect of GBE on RANKL‐induced osteoclast differentiation and function, we performed TRAP and F‐actin staining, as well as a bone‐resorbing assay. The intracellular mechanisms of GBE responsible for the regulation of osteoclastogenesis were revealed by Western blot analysis and quantitative real‐time polymerase chain reaction. We investigated the relationship between GBE and expression of osteoclast‐specific molecules to further elucidate the underlying mechanisms. It was found that GBE significantly suppressed osteoclastogenesis by decreasing the phosphorylation of Akt, p38, JNK, and ERK, as well as Btk‐PLCγ2 signaling, in pathways involved in early osteoclastogenesis as well as through the subsequent suppression of c‐Fos, NFATc1, and osteoclastogenesis‐specific marker genes. Additionally, GBE inhibited the formation of F‐actin ring‐positive osteoclasts and bone resorption activity of mature osteoclasts. Our findings suggest that GBE is a potential functional food and therapeutic candidate for bone diseases involving osteoclasts.